Healthcare provider profile · identity verified

Albert A Cabala, MD

Internal Medicine · KALAMAZOO, MI · NPI 1124098694

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	600	153
Rosuvastatin Calcium	Rosuvastatin Calcium	346	103
Levothyroxine Sodium	Levothyroxine Sodium	333	90
Lisinopril	Lisinopril	307	81
Amlodipine Besylate	Amlodipine Besylate	256	69
Losartan Potassium	Losartan Potassium	253	70
Hydrochlorothiazide	Hydrochlorothiazide	192	47
Metformin Hcl Er	Metformin Hcl	174	46
Tamsulosin Hcl	Tamsulosin Hcl	172	47
Omeprazole	Omeprazole	170	50
Pantoprazole Sodium	Pantoprazole Sodium	155	40
Metformin Hcl	Metformin Hcl	134	33
Metoprolol Succinate	Metoprolol Succinate	132	38
Sertraline Hcl	Sertraline Hcl	131	35
Gabapentin	Gabapentin	128	35
Ozempic	Semaglutide	120	18
Alprazolam	Alprazolam	116	38
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	108	26
Irbesartan	Irbesartan	92	23
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	90	24
Jardiance	Empagliflozin	78	19
Allopurinol	Allopurinol	75	17
Trazodone Hcl	Trazodone Hcl	74	23
Pravastatin Sodium	Pravastatin Sodium	73	19
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	72	21
Carvedilol	Carvedilol	70	19
Eliquis	Apixaban	70	21
Zolpidem Tartrate	Zolpidem Tartrate	67	18
Escitalopram Oxalate	Escitalopram Oxalate	65	21
Olmesartan Medoxomil	Olmesartan Medoxomil	65	13
Tramadol Hcl	Tramadol Hcl	65	16
Spironolactone	Spironolactone	64	17
Celecoxib	Celecoxib	62	19
Alendronate Sodium	Alendronate Sodium	57	20
Ipratropium Bromide	Ipratropium Bromide	56	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	55	13
Albuterol Sulfate Hfa	Albuterol Sulfate	54	24
Bupropion Xl	Bupropion Hcl	54	14
Furosemide	Furosemide	54	16
Finasteride	Finasteride	53	11
Simvastatin	Simvastatin	52	17
Synthroid	Levothyroxine Sodium	52	13
Montelukast Sodium	Montelukast Sodium	50	13
Citalopram Hbr	Citalopram Hydrobromide	46	14
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	41	19
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	40	12
Potassium Chloride	Potassium Chloride	39	11
Famotidine	Famotidine	38	suppressed
Prednisone	Prednisone	37	19
Torsemide	Torsemide	37	11
Trulicity	Dulaglutide	37	suppressed
Atenolol	Atenolol	36	suppressed
Mounjaro	Tirzepatide	34	suppressed
Fluticasone Propionate	Fluticasone Propionate	33	18
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	33	suppressed
Clopidogrel	Clopidogrel Bisulfate	31	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	31	suppressed
Valacyclovir	Valacyclovir Hcl	31	14
Metoprolol Tartrate	Metoprolol Tartrate	30	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	28	26
Farxiga	Dapagliflozin Propanediol	27	suppressed
Glipizide	Glipizide	27	suppressed
Cephalexin	Cephalexin	26	20
Ezetimibe	Ezetimibe	26	suppressed
Azelastine Hcl	Azelastine Hcl	25	suppressed
Duloxetine Hcl	Duloxetine Hcl	25	suppressed
Nitroglycerin	Nitroglycerin	25	suppressed
Propranolol Hcl	Propranolol Hcl	25	suppressed
Indapamide	Indapamide	24	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	24	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	24	suppressed
Oxycodone Hcl	Oxycodone Hcl	22	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	22	22
Sumatriptan Succinate	Sumatriptan Succinate	22	suppressed
Estradiol	Estradiol	21	suppressed
Glimepiride	Glimepiride	21	suppressed
Ibuprofen	Ibuprofen	21	14
Mirtazapine	Mirtazapine	20	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	19	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	19	suppressed
Incruse Ellipta	Umeclidinium Bromide	19	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	19	suppressed
Januvia	Sitagliptin Phosphate	19	suppressed
Diltiazem Hcl	Diltiazem Hcl	18	suppressed
Paroxetine Hcl	Paroxetine Hcl	18	suppressed
Pregabalin	Pregabalin	18	suppressed
Propranolol Hcl Er	Propranolol Hcl	18	suppressed
Repatha Sureclick	Evolocumab	18	suppressed
Rybelsus	Semaglutide	18	suppressed
Baclofen	Baclofen	17	suppressed
Chlorthalidone	Chlorthalidone	17	suppressed
Ketoconazole	Ketoconazole	17	12
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	17	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	17	12
Colestipol Hcl	Colestipol Hcl	16	suppressed
Entresto	Sacubitril/Valsartan	16	suppressed
Hydralazine Hcl	Hydralazine Hcl	16	suppressed
Diclofenac Sodium	Diclofenac Sodium	15	suppressed
Lorazepam	Lorazepam	15	suppressed
Rabeprazole Sodium	Rabeprazole Sodium	15	suppressed
Verapamil Er	Verapamil Hcl	15	suppressed
Xarelto	Rivaroxaban	15	suppressed
Amoxicillin	Amoxicillin	14	suppressed
Benazepril Hcl	Benazepril Hcl	14	suppressed
Sulindac	Sulindac	14	suppressed
Testosterone	Testosterone	14	suppressed
Acyclovir	Acyclovir	13	suppressed
Azithromycin	Azithromycin	13	12
Isosorbide Mononitrate Er	Isosorbide Mononitrate	13	suppressed
Premarin	Estrogens, Conjugated	13	suppressed
Testosterone Cypionate	Testosterone Cypionate	13	suppressed
Tresiba Flextouch U-100	Insulin Degludec	13	suppressed
Xultophy 100-3.6	Insulin Degludec/Liraglutide	13	suppressed
Arnuity Ellipta	Fluticasone Furoate	12	suppressed
Breo Ellipta	Fluticasone/Vilanterol	12	suppressed
Enalapril Maleate	Enalapril Maleate	12	suppressed
Ibandronate Sodium	Ibandronate Sodium	12	suppressed
Symbicort	Budesonide/Formoterol Fumarate	12	suppressed
Warfarin Sodium	Warfarin Sodium	12	suppressed
Clonazepam	Clonazepam	11	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	11	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	11	suppressed
Novolog Flexpen	Insulin Aspart	11	suppressed
Sildenafil Citrate	Sildenafil Citrate	11	suppressed
Ultra-Fine Nano Pen Needle	Pen Needle, Diabetic	11	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	11	suppressed
Zolpidem Tartrate Er	Zolpidem Tartrate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error